Subscribe to Newsletter
Business & Regulation Business Practice, Standards & Regulation, Trends & Forecasts

All Eyes on EMA Approvals

The European Medicines Agency (EMA) recently released its “highlights of 2015” in terms of new medicine approvals. All in all, it seems that 2015 was a good year with 93 medicines recommended for marketing authorization, including 39 new active substances. In 2014, on the other hand, just 82 new products were recommended for approval. Our infographic brings you up to speed with some of the key approvals from 2015 that will likely be coming to a European market near you soon.

Cancer Approval Highlights:
Bringing Medicines to Patients Faster
Safety First

Inspections were conducted in 62 countries worldwide

>2,590 GMP inspections. >270 GCP inspections.
>190 pharmacovigilance inspections.

Medicines with New Active Substances in 2015
New Medicines for Rare Diseases: 18


Blincyto for patients with acute lymphoblastic leukemia
Farydak for patients with multiple myeloma
Hetlioz for blind adults with sleep-wake disorder
Kanuma for patients with lysosomal acid lipase deficiency
Kyprolis for patients with multiple myeloma
Lenvima for patients with thyroid cancer
Strensiq for patients with childhood hypophosphatasia
Unituxin for patients with brain cancer (neuroblastoma)

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine